P2.09-08 Gefitinib Maintenance After Definitive CCRT in EGFR mutant Stage III NSCLC: Single Arm, Open Label, Multicenter Phase 2 Trial

Y. Jang,C.-M. Choi,I.-J. Oh, Y.-C. Kim, W. Ji, J.C. Lee

Journal of Thoracic Oncology(2023)

引用 0|浏览0
暂无评分
关键词
gefitinib maintenance,egfr,mutant stage iii nsclc,definitive ccrt
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要